Molecular Pathology & Genomics

Congress: this is it!

With Congress 2017 now upon us, IBMS Deputy Chief Executive Sarah May gives a taster of some of the presentations.

Delivering the genomic dream

It is time to build a national, first-class genomic medicine industry that is scalable, futureproof, and delivers value for money.

International Space Station projects

Five “organs-on-chips” research experiments are set to take place on the International Space Station.

IBMS responds to Dame Sally's report

The IBMS has issued a response to Professor Dame Sally Davies’ annual report, which calls on the government to develop genomic medicine’s role in the NHS.

In situ hybridisation symposium report

Pathology Scientist Rebecca Sargeant reports on some highlights from the symposium “Applications of in situ hybridisation in research and disease”.

Congress: stay a while, learn a lot

Sarah May, Deputy Chief Executive at the IBMS, on the unprecedented breadth of content at this year’s Congress.

Breakthrough in Huntington’s disease

Ed Wild discusses the latest breakthrough in Huntington’s disease and explains why he will always remain dedicated to the field.

My lab: Immunocytochemistry and molecular pathology services

Sharon Forrest, Immunocytochemistry and Molecular Pathology Services Manager, gives a tour of her lab at the Royal Liverpool University Hospital.

Understanding motor neuron disease

Scientists have discovered how certain forms of motor neuron disease begin and progress at cellular and molecular levels. It is hoped that the findings could reveal potential new ways to slow down or even stop the disease’s progress. 


Patient-specific cells created

Scientists in the US have created blood-forming stem cells from patients’ own cells.

Converting skin to blood vessels

A molecular switch has been identified that converts skin cells into cells that are found in blood vessels.